producer themis bio science and would work with research nonprofit. to develop 2 separate vaccines now merck and also announced a new partnership with ridgeback biopharma bio therapeutics to work on an experimental oral anti-viral drug to combat covert 19 as far as timelines for these vaccines merck's says the theme is a vaccine will be ready to start vaccinating volunteers within weeks while the. vaccine will be ready for human trials at some point this year now meanwhile maryland based biotech firm novak's says it is ready to start clinical trials of its vaccine this week in australia citing optimism on the developments. with your technology like we're bringing to the table we know. could translate very well and so our optimism. for the company says it will inject 131 volunteers between the ages of 18 and 59 it to step. locations within